{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:52:22Z","timestamp":1790275942429,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T00:00:00Z","timestamp":1417478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00403-014-1522-2","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T18:36:41Z","timestamp":1417459001000},"page":"299-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Study of T helper 1 and T helper 2 responses in pemphigus vulgaris patients receiving interferon alpha 2a injections in addition to a standard protocol therapy: a randomized controlled trial"],"prefix":"10.1007","volume":"307","author":[{"given":"Mohammad A.","family":"El-Darouti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab A.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania M.","family":"Abdel Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa S.","family":"El Hawary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira M.","family":"Tawdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila A.","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,2]]},"reference":[{"key":"1522_CR1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1468-3083.2012.04582.x","volume":"27","author":"M Afshar","year":"2013","unstructured":"Afshar M, Martinez AD, Gallo RL, Hata TR (2013) Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases. J Eur Acad Dermatol Venereol 27:771\u2013778","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1522_CR2","first-page":"158","volume":"37","author":"M Agarwal","year":"1998","unstructured":"Agarwal M, Walia R, Kochhar AM, Chander R (1998) Pemphigus Area and Activity Score (PAAS)\u2014a novel clinical scoring method for monitoring of pemphigus vulgaris patients. Int J Dermatol 37:158\u2013160","journal-title":"Int J Dermatol"},{"issue":"2","key":"1522_CR3","first-page":"121","volume":"58","author":"M Alecu","year":"1999","unstructured":"Alecu M, Alecu S, Coman G, G\u0103l\u0103\u0163escu E, Ursaciuc C (1999) ICAM-1, ELAM-1, TNF-alpha and IL-6 in serum and blister liquid of pemphigus vulgaris patients. Roum Arch Microbiol Immunol 58(2):121\u2013130","journal-title":"Roum Arch Microbiol Immunol"},{"key":"1522_CR4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0684.2007.00221.x","volume":"37","author":"DM Asmuth","year":"2008","unstructured":"Asmuth DM, Abel K, George MD, Dandekar S, Pollard RB, Miller CJ (2008) Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques. J Med Primatol 37:26\u201330","journal-title":"J Med Primatol"},{"key":"1522_CR5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/bmj.321.7258.424","volume":"321","author":"A Berger","year":"2000","unstructured":"Berger A (2000) Th1 and Th2 responses: what are they? BMJ 321:424","journal-title":"BMJ"},{"key":"1522_CR6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0090-1229(90)90060-4","volume":"54","author":"P Bernard","year":"1990","unstructured":"Bernard P, Aucouturier P, Denis F, Bonnetblanc JM (1990) Immunoblot analysis of IgG subclasses of circulating antibodies in bullous pemphigoid. Clin Immunol Immunopathol 54:489\u2013494","journal-title":"Clin Immunol Immunopathol"},{"key":"1522_CR7","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1073\/pnas.92.11.5239","volume":"92","author":"K Bhol","year":"1995","unstructured":"Bhol K, Natarajan K, Nagarwalla N, Mohimen A, Aoki V, Ahmed AR (1995) Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc Natl Acad Sci USA 92:5239\u20135243","journal-title":"Proc Natl Acad Sci USA"},{"key":"1522_CR8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/clim.2000.4974","volume":"98","author":"M Caproni","year":"2001","unstructured":"Caproni M, Giomi B, Cardinali C, Salvatore E, Pestelli E, D\u2019Agata A, Bianchi B et al (2001) Further support for a role for Th2-like cytokines in blister formation of pemphigus. Clin Immunol 98:264\u2013271","journal-title":"Clin Immunol"},{"key":"1522_CR9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2133.2000.03661.x","volume":"143","author":"S Christophoridis","year":"2000","unstructured":"Christophoridis S, B\u00fcdinger L, Borradori L, Hunziker T, Merk HF, Hertl M (2000) IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous disease. Br J Dermatol 143:349\u2013355","journal-title":"Br J Dermatol"},{"key":"1522_CR10","first-page":"383","volume":"8","author":"L D\u2019Auria","year":"1997","unstructured":"D\u2019Auria L, Bonifati C, Mussi A, D\u2019Agosto G, De Simone C, Giacalone B et al (1997) Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity. Eur Cytokine Netw 8:383\u2013387","journal-title":"Eur Cytokine Netw"},{"key":"1522_CR11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2133.2009.09208.x","volume":"161","author":"M El-Darouti","year":"2009","unstructured":"El-Darouti M, Marzouk S, Abdel Hay R, el-Tawdy A, Fawzy M, Leheta T et al (2009) The use of sulfasalazine and pentoxifylline (low-cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study. Br J Dermatol 161:313\u2013319","journal-title":"Br J Dermatol"},{"key":"1522_CR12","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1046\/j.1365-2133.2000.03901.x","volume":"143","author":"R Eming","year":"2000","unstructured":"Eming R, B\u00fcdinger L, Riechers R, Christensen O, Bohlen H, Kalish R et al (2000) Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay. Br J Dermatol 143:1279\u20131282","journal-title":"Br J Dermatol"},{"key":"1522_CR13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000246315","volume":"192","author":"M Fleischmann","year":"1996","unstructured":"Fleischmann M, Celerier P, Bernard P, Litoux P, Dreno B (1996) Long-term\u00a0interferon-alpha therapy induces autoantibodies against epidermis. Dermatology 192:50\u201355","journal-title":"Dermatology"},{"key":"1522_CR14","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI28547","volume":"116","author":"M Hertl","year":"2006","unstructured":"Hertl M, Eming R, Veldman C (2006) T cell control in autoimmune bullous skin disorders. J Clin Invest 116:1159\u20131166","journal-title":"J Clin Invest"},{"key":"1522_CR15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2133.1995.tb08688.x","volume":"132","author":"RS Kirsner","year":"1995","unstructured":"Kirsner RS, Anhalt GJ, Kerdel FA (1995) Treatment with alpha\u00a0interferon\u00a0associated with the development of paraneoplastic\u00a0pemphigus. Br J Dermatol 132:474\u2013478","journal-title":"Br J Dermatol"},{"key":"1522_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1172\/JCI119130","volume":"99","author":"MS Lin","year":"1997","unstructured":"Lin MS, Swartz SJ, Lopez A, Fernandez-Vina MA, Stastny P, Fairley JA et al (1997) Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest 99:31\u201340","journal-title":"J Clin Invest"},{"key":"1522_CR17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/JVI.76.1.432-435.2002","volume":"76","author":"D Markine-Goriaynoff","year":"2002","unstructured":"Markine-Goriaynoff D, Coutelier J-P (2002) Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants. J Virol 76:432\u2013435","journal-title":"J Virol"},{"key":"1522_CR18","first-page":"237","volume":"15","author":"Y Nagao","year":"2005","unstructured":"Nagao Y, Kawaguchi T, Ide T, Kumashiro R, Sata M (2005) Exacerbation of oral erosive\u00a0lichen planus\u00a0by combination of\u00a0interferon\u00a0and ribavirin therapy for chronic hepatitis C. Int J Mol Med 15:237\u2013241","journal-title":"Int J Mol Med"},{"key":"1522_CR19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.clim.2009.11.006","volume":"134","author":"A Nagel","year":"2010","unstructured":"Nagel A, Lang A, Engel D, Podstawa E, Hunzelmann N, de Pita O et al (2010) Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3. Clin Immunol 134:320\u2013330","journal-title":"Clin Immunol"},{"issue":"Suppl 1","key":"1522_CR20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000246954","volume":"189","author":"H Niizeki","year":"1994","unstructured":"Niizeki H, Inamoto N, Nakamura K, Tsuchimoto K, Hashimoto T, Nishikawa T (1994) A case of\u00a0pemphigus\u00a0foliaceus after\u00a0interferon\u00a0alpha-2a therapy. Dermatology 189(Suppl 1):129\u2013130","journal-title":"Dermatology"},{"key":"1522_CR21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000247329","volume":"186","author":"A Parodi","year":"1993","unstructured":"Parodi A, Semino M, Gallo R, Rebora A (1993) Bullous eruption with circulating\u00a0pemphigus-like antibodies following\u00a0interferon-alpha therapy. Dermatology 186:155\u2013157","journal-title":"Dermatology"},{"key":"1522_CR22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/jamadermatol.2013.8175","volume":"150","author":"Z Rahbar","year":"2014","unstructured":"Rahbar Z, Daneshpazhooh M, Mirshams-Shahshahani M, Esmaili N, Heidari K, Aghazadeh N et al (2014) Pemphigus disease activity measurements: pemphigus disease area index, autoimmune bullous skin disorder intensity score, and pemphigus vulgaris activity score. JAMA Dermatol 150:266\u2013272","journal-title":"JAMA Dermatol"},{"key":"1522_CR23","first-page":"332","volume":"80","author":"MG Rico-Rosillo","year":"2012","unstructured":"Rico-Rosillo MG, Vega-Robledo GB (2012) Immunological mechanisms involved in\u00a0pregnancy. Ginecol Obstet Mex 80:332\u2013340","journal-title":"Ginecol Obstet Mex"},{"key":"1522_CR24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4049\/jimmunol.170.1.635","volume":"170","author":"C Veldman","year":"2003","unstructured":"Veldman C, Stauber A, Wassmuth R, Uter W, Schuler G, Hertl M (2003) Dichotomy of autoreactive Th1 and TH2 responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles. J Immunol 170:635\u2013642","journal-title":"J Immunol"},{"key":"1522_CR25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00002018-199410020-00003","volume":"10","author":"T Vial","year":"1994","unstructured":"Vial T, Descotes J (1994) Clinical toxicity of the\u00a0interferons. Drug Saf 10:115\u2013150","journal-title":"Drug Saf"},{"key":"1522_CR26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1346-8138.2009.00797.x","volume":"37","author":"T Yokoyama","year":"2010","unstructured":"Yokoyama T, Amagai M (2010) Immune dysregulation of pemphigus in humans and mice. J Dermatol 37:205\u2013213","journal-title":"J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-014-1522-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-014-1522-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-014-1522-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T13:30:13Z","timestamp":1717594213000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-014-1522-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,2]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1522"],"URL":"https:\/\/doi.org\/10.1007\/s00403-014-1522-2","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,2]]}}}